Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01778647 · ClinicalTrials.gov registry record · Phase 4
Omega-3 Fatty Acids as an Adjunctive Therapy for Stimulants in Children With ADHD
A Phase 4 study, sponsored by Antonios Likourezos.
- Terminated
- Registry status
- Phase 4
- Development phase
- 15
- Enrollment target
NCT01778647: Clinical Trial Phase 4 study, sponsored by Antonios Likourezos.
NCT01778647 is a Phase 4 study that was terminated before completion, run by Antonios Likourezos. The registered enrollment target is 15 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01778647, a Phase 4 study, was terminated before completion, sponsored by Antonios Likourezos.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 15 participants
- Enrollment target
Study Summary
Multiple forms of Omega-3 Fatty acids have been used to investigate the role of this food supplement in children with Attention Deficit Hyperactivity Disorder (ADHD). No clear evidence for their role in this disorder is yet available. We will conduct a prospective, randomized, double blind, placebo controlled trial to obtain significant results regarding this question.
Primary Outcome
Conners Rating Scales is designed to provide an overview of child and adolescent concerns and disorders, including ADHD. The survey for parents contains 80 items and 59 items for teachers. Scoring is based on a response about specific aspects of child behavior, with a low cumulative score showing less likelihood of a specific disorder. The cumulative score is called a T-score. T-scores have a mean of 50 and a standard deviation of 10. These can be converted to percentile scores. T-scores above 6
Interventions
- DIETARY_SUPPLEMENT Stimulants plus Lovaza
- DRUG Stimulants plus placebo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2009-12 |
| Est. Completion | 2010-07 |
| Phase | Phase 4 |
Why NCT01778647 stopped before completion
NCT01778647 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 15 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (97% lower).
The record links to 0 conditions, and to 2 interventions - of which Stimulants plus Lovaza is the first listed.
NCT01778647 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01778647 about?
NCT01778647 is a clinical study titled "Omega-3 Fatty Acids as an Adjunctive Therapy for Stimulants in Children With ADHD". Multiple forms of Omega-3 Fatty acids have been used to investigate the role of this food supplement in children with Attention Deficit Hyperactivity Disorder (ADHD). No clear evidence for their role in this disorder is yet available. We will conduct a prospective, randomized, double blind, placebo ...
What is the current status of trial NCT01778647?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 15 participants. The study started on 2009-12. Estimated completion is 2010-07.
What interventions are being tested in trial NCT01778647?
The interventions under investigation include: Stimulants plus Lovaza (DIETARY_SUPPLEMENT), Stimulants plus placebo (DRUG).
Who is sponsoring clinical trial NCT01778647?
This trial is sponsored by Antonios Likourezos, which has 33 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01778647's enrollment target sits among peer trials
15 1880th of 2000 higher than 100 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01889381 · 15 participants · Phase 2
Human Craniomaxillofacial Allotransplantation
- NCT02530073 · 15 participants · NA
Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) for CDH
- NCT02535936 · 15 participants · NA
Cortical Plasticity in Spastic Diplegia After Selective Dorsal Rhizotomy
- NCT02918474 · 15 participants · NA
Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia